News

The latest news from the pharmaceutical industry. If you have a piece of news that you would like us to cover, please contact Pippa McCartney on +44(0) 1959 563311 or email us.

Kevin W. Sharer, chairman and chief executive officer of Amgen since 2000

Sharer to step down as chairman and chief executive officer of Amgen

19 December 2011
Kevin W. Sharer has announced his plan to retire from the Company at the end of 2012...

Bristol Myers Squibb logo

Simcere and Bristol-Myers Squibb enter innovative partnership to develop cardiovascular compound

15 December 2011
The companies have expanded the strategic partnership formed last year...

Bayer logo

New Intrauterine System for long-term contraception submitted for marketing authorization both in the EU and the U.S.

15 December 2011
Once approved, the new low dose IUS will offer contraception for up to three years...

Amgen logo

Final results from largest phase 3 open-label study assessing Nplate®

15 December 2011
Additional key Nplate (Romiplostim) data also presented at American Society of Hematology annual meeting...

Merck logo

Merck announces initiation of clinical development collaboration with Roche

15 December 2011
New clinical trial will evaluate an investigational therapeutic regimen with VICTRELIS™ (boceprevir)...

Roche logo

Changes to the Roche Corporate Executive Committee

15 December 2011
Roche announced that Sophie Kornowski-Bonnet has been appointed Head of Roche Partnering...

Novartis logo

Novartis drug Gilenya® showed positive clinical outcomes for relapsing-remitting MS patients in third large Phase III clinical trial

15 December 2011
Once-daily oral MS medicine showed a 48% relative reduction in annualized relapse rate, meeting primary endpoint in Phase III placebo-controlled study...

GlaxoSmithKline logo

GlaxoSmithKline and Human Genome Sciences initiate phase III trial of belimumab (Benlysta®) administered subcutaneously in subjects with systemic lupus erythematosus

15 December 2011
Study to enrol over 800 adult patients with systemic lupus erythematosus...

AstraZeneca

G-BA issues positive final medical benefit assessment for BRILIQUE in Germany

15 December 2011
AstraZeneca announced that the German assessment body, the Federal Joint Committee (G-BA), has issued its final decision regarding the medical benefit of BRILIQUE (ticagrelor)...

Syrris

Syrris chemical reactors – good under pressure

14 December 2011
Syrris, offers a range of reactors designed specifically for applications requiring elevated pressures...

Boehringer_Ingelheim

Boehringer Ingelheim significantly expands its supply center for China

14 December 2011
Boehringer Ingelheim announced that the company intends to invest 70 million Euro to expand its manufacturing plant in the Zhangjiang High-Tech Park in Shanghai...

Novartis logo

New Phase III data shows Novartis JAK inhibitor INC424 significantly reduced disease burden in patients with myelofibrosis

13 December 2011
Results from two pivotal Phase III trials...